lantronix_10q-033108.htm


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549


 
FORM 10-Q
 
 
x QUARTERLY REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2008

OR
 
o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES ACT OF 1934
 
For the transition period from _________ to ___________.

Commission file number: 1-16027



LANTRONIX, INC.
(Exact name of registrant as specified in its charter)

Delaware
33-0362767
(State or other jurisdiction
(I.R.S. Employer
of incorporation or organization)
Identification No.)
 
15353 Barranca Parkway, Irvine, California
(Address of principal executive offices)
 
92618
(Zip Code)
 

 
(949) 453-3990
(Registrant’s telephone number, including area code)

Former name, former address and former fiscal year, if changed since last report: N/A
 
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No o
 
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):
 
Large accelerated filer o
Accelerated filer o
Non-accelerated filer o
Smaller reporting company x
 
Indicate by check mark whether the registrant is a shell company (as defined by Rule 12b-2 of the Exchange Act).  Yes o No x.
 
As of May 7, 2008, 60,312,363 shares of the Registrant’s common stock were outstanding.



 
LANTRONIX, INC.

FORM 10-Q
FOR THE FISCAL QUARTER ENDED
March 31, 2008

INDEX

     
Page
       
PART I.
FINANCIAL INFORMATION                                                                                                                            
 
1
       
Item 1.
Financial Statements.                                                                                                                            
 
1
       
 
Unaudited Condensed Consolidated Balance Sheets at March 31, 2008 and June 30, 2007
 
1
       
 
Unaudited Condensed Consolidated Statements of Operations for the Three and Nine Months Ended
 
 
 
March 31, 2008 and 2007                                                                                                                         
 
2
       
 
Unaudited Condensed Consolidated Statements of Cash Flows for the Nine Months Ended
   
 
March 31, 2008 and 2007                                                                                                                         
 
3
       
 
Notes to Unaudited Condensed Consolidated Financial Statements.                                                                                                                            
 
4
       
Item 2.
Management’s Discussion and Analysis of Financial Condition and Results of Operations
 
8
       
Item 3.
Quantitative and Qualitative Disclosures About Market Risk.                                                                                                                            
 
18
       
Item 4.
Controls and Procedures.                                                                                                                            
 
19
       
PART II.
OTHER INFORMATION                                                                                                                            
 
19
       
Item 1.
Legal Proceedings                                                                                                                            
 
19
       
Item 1A.
Risk Factors
 
19
       
Item 2.
Unregistered Sales of Equity Securities and Use of Proceeds.                                                                                                                            
 
27
       
Item 3.
Defaults Upon Senior Securities                                                                                                                            
 
28
       
Item 4.
Submission of Matters to a Vote of Security Holders                                                                                                                            
 
28
       
Item 5.
Other Information                                                                                                                            
 
28
       
Item 6.
Exhibits                                                                                                                            
 
28

 
 

 

PART I. FINANCIAL INFORMATION

Item 1.  Financial Statements

LANTRONIX, INC.

UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS
 
 
   
March 31,
   
June 30,
 
   
2008
   
2007
 
   
(In thousands)
 
ASSETS
           
Current Assets:
           
Cash and cash equivalents
  $ 7,297     $ 7,582  
Marketable securities
    -       97  
Accounts receivable, net
    2,833       3,411  
Inventories, net
    8,079       10,981  
Contract manufacturers' receivable
    1,321       1,270  
Prepaid expenses and other current assets
    744       578  
Total current assets
    20,274       23,919  
                 
Property and equipment, net
    2,106       1,911  
Goodwill
    9,488       9,488  
Purchased intangible assets, net
    409       485  
Officer loans
    94       129  
Other assets
    43       26  
Total assets
  $ 32,414     $ 35,958  
                 
LIABILITIES AND STOCKHOLDERS' EQUITY
               
Current Liabilities:
               
Accounts payable
  $ 7,483     $ 11,017  
Accrued payroll and related expenses
    1,934       1,993  
Warranty reserve
    342       446  
Accrued settlements
    -       1,068  
Other current liabilities
    3,620       3,808  
Total current liabilities
    13,379       18,332  
Long-term liabilities
    214       256  
Long-term capital lease obligations
    552       142  
                 
Commitments and contingencies
               
                 
Stockholders' equity:
               
Common stock
    6       6  
Additional paid-in capital
    187,264       184,953  
Accumulated deficit
    (169,533 )     (168,173 )
Accumulated other comprehensive income
    532       442  
Total stockholders' equity
    18,269       17,228  
Total liabilities and stockholders' equity
  $ 32,414     $ 35,958  
 
See accompanying notes.
 
1


LANTRONIX, INC.

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

 
   
Three Months Ended
March 31,
   
Nine Months Ended
March 31,
 
   
2008
   
2007
   
2008
   
2007
 
   
(In thousands, except per share data)
 
                         
Net revenues (1)
  $ 14,541     $ 13,253     $ 42,872     $ 40,596  
Cost of revenues (2)
    7,207       6,387       21,234       19,723  
Gross profit
    7,334       6,866       21,638       20,873  
Operating expenses:
                               
Selling, general and administrative
    5,982       6,001       17,592       17,556  
Research and development
    1,707       1,898       5,233       5,498  
Litigation settlement costs
    -       -       -       90  
Amortization of purchased intangible assets
    18       18       54       54  
Total operating expenses
    7,707       7,917       22,879       23,198  
Loss from operations
    (373 )     (1,051 )     (1,241 )     (2,325 )
Interest expense, net
    (39 )     (11 )     (119 )     (4 )
Other (expense) income, net
    (16 )     6       115       733  
Loss before income taxes
    (428 )     (1,056 )     (1,245 )     (1,596 )
Provision (benefit) for income taxes
    36       14       (111 )     38  
Net loss
  $ (464 )   $ (1,070 )   $ (1,134 )   $ (1,634 )
                                 
Net loss per share (basic and diluted)
  $ (0.01 )   $ (0.02 )   $ (0.02 )   $ (0.03 )
                                 
Weighted-average shares (basic and diluted)
    60,192       59,709       60,074       59,511  
                                 
(1)  Includes net revenues from related party
  $ 196     $ 209     $ 698     $ 790  
                                 
(2)  Includes amortization of purchased intangible assets
  $ 9     $ 5     $ 22     $ 11  
 
See accompanying notes.

2


LANTRONIX, INC.

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
 
 
   
Nine Months Ended
 
    March 31,  
   
2008
   
2007
 
   
(In thousands)
 
Cash flows from operating activities:
           
Net loss
  $ (1,134 )   $ (1,634 )
Adjustments to reconcile net loss to net cash used in operating activities:
               
Share-based compensation
    928       1,048  
Provision (recovery) for inventories
    362       (141 )
Depreciation and amortization
    406       287  
Gain on sale of investment
    (104 )     (700 )
Amortization of purchased intangible assets
    76       65  
Provision for officer loan
    35       -  
(Recovery) Provision for doubtful accounts
    (16 )     23  
Litigation settlement costs
    -       90  
Changes in operating assets and liabilities:
               
Accounts receivable
    594       309  
Inventories
    2,540       (1,580 )
Contract manufacturers' receivable
    (51 )     (305 )
Prepaid expenses and other current assets
    (139 )     48  
Other assets
    11       (3 )
Accounts payable
    (3,543 )     2,403  
Accrued payroll and related expenses
    (104 )     171  
Accrued settlements
    -       (400 )
Warranty reserve
    (104 )     (248 )
Other liabilities
    (141 )     (644 )
Net cash used in operating activities
    (384 )     (1,211 )
Cash flows from investing activities:
               
Purchases of property and equipment, net
    (383 )     (396 )
Proceeds from the sale of investment
    104       700  
Net cash (used) provided in investing activities
    (279 )     304  
Cash flows from financing activities:
               
Net proceeds from issuances of common stock
    326       708  
Payment of capital lease obligations
    (148 )     (111 )
Net cash provided by financing activities
    178       597  
Effect of foreign exchange rate changes on cash
    200       64  
Decrease in cash and cash equivalents
    (285 )     (246 )
Cash and cash equivalents at beginning of period
    7,582       7,729  
Cash and cash equivalents at end of period
  $ 7,297     $ 7,483  
 
See accompanying notes.
 
3


LANTRONIX, INC.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

March 31, 2008

1.    Basis of Presentation

The accompanying unaudited condensed consolidated financial statements of Lantronix, Inc. (the “Company” or “Lantronix”) have been prepared by the Company in accordance with generally accepted accounting principles (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 10 of Regulation S-X.  Accordingly, they should be read in conjunction with the audited consolidated financial statements and notes thereto for the fiscal year ended June 30, 2007, included in the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission (“SEC”) on September 11, 2007. They contain all normal recurring accruals and adjustments which, in the opinion of management, are necessary to present fairly the consolidated financial position of the Company at March 31, 2008, and the consolidated results of its operations and cash flows for the three and nine months ended March 31, 2008 and 2007.  All intercompany accounts and transactions have been eliminated. It should be understood that accounting measurements at interim dates inherently involve greater reliance on estimates than at year-end. The results of operations for the three and nine months ended March 31, 2008 are not necessarily indicative of the results to be expected for the full year or any future interim periods.
 
2.    Computation of Net Loss per Share

Basic and diluted net loss per share is calculated by dividing net loss by the weighted-average number of common shares outstanding during the year.
 
The following table presents the computation of net loss per share:

   
Three Months Ended
March 31,
   
Nine Months Ended
March 31,
 
   
2008
   
2007
   
2008
   
2007
 
   
(In thousands, except per share data)
 
Numerator:
                       
Net loss
  $ (464 )   $ (1,070 )   $ (1,134 )   $ (1,634 )
Denominator:
                               
Weighted-average shares
    60,292       59,709       60,174       59,511  
Less: Unvested common shares outstanding
    (100 )     -       (100 )     -  
Weighted-average shares (basic and diluted)
    60,192       59,709       60,074       59,511  
                                 
Net loss per share (basic and diluted)
  $ (0.01 )   $ (0.02 )   $ (0.02 )   $ (0.03 )
 
The following table presents the common stock equivalents excluded from the diluted net loss per share calculation, because they were anti-dilutive as of such dates.  These excluded common stock equivalents could be dilutive in the future.

   
Three Months Ended
March 31,
   
Nine Months Ended
March 31,
 
   
2008
   
2007
   
2008
   
2007
 
Common stock equivalents
    4,598,715       2,161,000       3,861,280       2,594,000  
 
4

 
3.    Inventories

Inventories are stated at the lower of cost (first-in, first-out) or market and consist of the following:
 
   
March 31,
   
June 30,
 
   
2008
   
2007
 
   
(In thousands)
 
Finished goods
  $ 6,298     $ 7,848  
Raw materials
    1,819       2,653  
Inventory at distributors
    1,553       1,876  
Large scale integration chips *
    1,171       1,530  
Inventories, gross
    10,841       13,907  
Reserve for excess and obsolete inventory
    (2,762 )     (2,926 )
Inventories, net
  $ 8,079     $ 10,981  
                 
* This item is sold individually and embedded into the Company's products.
               

4.    Warranty

Upon shipment to its customers, the Company provides for the estimated cost to repair or replace products to be returned under warranty.  The Company’s products typically carry a one- to two-year warranty. In addition, certain products that were sold prior to August 2003 carry a five-year warranty.  Although the Company engages in extensive product quality programs and processes, its warranty obligation is affected by product failure rates, use of materials or service delivery costs that differ from the Company’s estimates. As a result, additional warranty reserves could be required, which could reduce gross margins. Additionally, the Company sells extended warranty services, which extend the warranty period for an additional one to three years depending upon the product.
 
The following table is a reconciliation of the changes to the product warranty liability for the periods presented:

   
Nine Months
Ended
   
Year Ended
 
   
March 31,
   
June 30,
 
   
2008
   
2007
 
   
(In thousands)
 
Beginning balance
  $ 446     $ 693  
Charged to cost of revenues
    143       107  
Usage
    (247 )     (354 )
Ending balance
  $ 342     $ 446  

5.             Bank Line of Credit and Debt

In May 2006, the Company entered into a two-year secured revolving Loan and Security Agreement ("Line of Credit”) with a bank, which provides for borrowings up to $5.0 million. The borrowing capacity is limited to eligible accounts receivable as defined under the Line of Credit. Borrowings under the Line of Credit bear interest at the prime rate plus 1.75% per annum. The Company is required to pay an unused line fee of 0.50% on the unused portion of the Line of Credit. In addition, the Company paid a fully earned, non-refundable commitment fee of $54,000 and paid an additional $54,000 on the first anniversary of the effective date of the Line of Credit.  The Line of Credit expires in May 2008.  The Company is currently negotiating terms for a new debt agreement.
 
The Company's obligations under the Line of Credit are secured by substantially all of the Company's assets, including its intellectual property.
 
The Company is subject to a number of covenants under the Line of Credit, pursuant to which, among other things, the Company has agreed that it will not, without the bank's prior written consent: (a) sell, lease, transfer or otherwise dispose, any of the Company's business or property, provided, however, that the Company may sell inventory in the ordinary course of business consistent with the provisions of the Line of Credit; (b) change the Company's business structure, liquidate or dissolve, or permit a change in beneficial ownership of more than 20% of the outstanding shares; (c) acquire, merge or consolidate with or into any other business organization; (d) incur any debts outside the ordinary course of the Company's business, except for permitted indebtedness, or grant any security interests in or permit a lien, claim or encumbrance upon all or any portion of the Company's assets, except in favor of or agreed to by the bank; (e) make any investments other than permitted investments; (f) make or permit any payments on any subordinated debt, except under the terms of existing subordinated debt or on terms acceptable to the bank, or amend any provision in any document related to the subordinated debt that would increase the amount thereof, or (g) become an "investment company" as such term is defined under the Investment Company Act of 1940. The Line of Credit also contains a number of affirmative covenants, including, among other things, covenants regarding the delivery of financial statements and notice requirements, accounts receivable, payment of taxes, access to collateral and books and records, maintenance of properties and insurance policies, and litigation by third parties.
 
5

 
The Line of Credit includes events of default that include, among other things, non-payment of principal, interest or fees, violation of affirmative and negative covenants, cross default to certain other indebtedness, material adverse change, material judgments, bankruptcy and insolvency events.
 
As of March 31, 2008, the Company had no borrowings against the Line of Credit.

6.    Share-Based Compensation

The following table presents a summary of option activity under the Company’s stock option plans:
 
   
Number of
 
   
Shares
 
Balance of options outstanding at June 30, 2007
    5,891,896  
Options granted
    4,437,450  
Options forfeited
    (956,888 )
Options expired
    (449,166 )
Options exercised
    (124,396 )
Balance of options outstanding at March 31, 2008
    8,798,896  
 
The following table presents stock option grant date information:
 
   
Three Months Ended
March 31,
   
Nine Months Ended
March 31,
 
   
2008
   
2007
   
2008
   
2007
 
Weighted-average grant date fair value
  $ 0.57     $ 1.29     $ 0.58     $ 1.25  
Weighted-average grant date exercise price
  $ 0.82     $ 1.69     $ 0.84     $ 1.63  
 
During the quarter ended March 31, 2008, the Board of Directors approved a market performance grant, which included 2,715,000 stock options and 100,000 restricted shares to members of the executive management team and the Board of Directors.  These market performance grants include service-based vesting and become exercisable as follows:  one year after the date of grant, 30% of these grants vest; two years after the date of grant, an additional 30% of these grants vest; and three years after the date of grant, the final 40% of these grants vest.   These grants include a market performance condition that accelerates the vesting if the Company’s stock price is equal to, or exceeds the following stock prices during each of the 120 preceding calendar days:  $1.50, 30% of the vesting is accelerated; $2.50, an additional 30% of the vesting is accelerated; and $4.00, the final 40% of the vesting is accelerated.  The grants had an exercise price that was equal to the market price of the Company’s common stock at the date of the grant.  The weighted-average exercise price of the grants was $0.78.  The grants had a weighted-average fair value of $0.53 and derived service period of 3-years.  As of March 31, 2008, the unamortized balance of share-based compensation related to these grants is $1.4 million, which will be expensed ratably over the 3-year derived service period.  However, if a market performance condition is met prior to the completion of the derived service period, then the respective share-based compensation expense will be accelerated into the period that the performance condition is met.
 
The following table presents a summary of share-based compensation by functional line item:
 
   
Three Months Ended
March 31,
   
Nine Months Ended
March 31,
 
   
2008
   
2007
   
2008
   
2007
 
         
(In thousands)
     
Cost of revenues
  $ 27     $ 25     $ 80     $ 61  
Selling, general and administrative
    186       292       588       702  
Research and development
    74       97       260       285  
Total share-based compensation
  $ 287     $ 414     $ 928     $ 1,048  
 
7.    Income Taxes
 
On July 1, 2007, the Company adopted Financial Accounting Standards Board Interpretation No. 48, “Accounting for Uncertainty in Income Taxes, an Interpretation of FASB Statement No. 109” (“FIN 48”).  In connection with the adoption of FIN 48, the Company recognized an adjustment of approximately $226,000 to the beginning balance of accumulated deficit on its consolidated balance sheet.  The Company’s continuing practice is to recognize interest and/or penalties related to income tax matters in income tax expense. As of March 31, 2008, the Company had recorded $151,000 of uncertain tax positions including approximately $74,000 of accrued interest and penalties related to these uncertain tax positions.
 
6

 
At July 1, 2007, the Company’s fiscal 2001 through fiscal 2007 tax years remain open to examination by the major taxing jurisdictions to which the Company is subject.  However, the Company has federal and state net operating losses (“NOLs”) beginning in fiscal 2001 which would cause the statute of limitations to remain open for the year in which the NOL was incurred.
 
The Company utilizes the liability method of accounting for income taxes.  The following table presents the Company’s effective tax rates based upon the income tax provision for the periods shown:
 
   
Three Months Ended
March 31,
   
Nine Months Ended
March 31,
 
   
2008
   
2007
   
2008
   
2007
 
Effective tax rate
    8%       1%       9%       2%  
 
The federal statutory rate was 34% for all periods.  The tax benefit during the nine months ended March 31, 2008 is the result of a reduction in estimated foreign taxes and penalties.  The difference between our effective tax rate and the federal statutory rate resulted primarily from the effect of our domestic losses recorded without a tax benefit, as well as the effect of foreign earnings taxed at rates differing from the federal statutory rate.

8.           Comprehensive Loss

The components of comprehensive loss are as follows:
 
   
Three Months Ended
March 31,
   
Nine Months Ended
March 31,
 
   
2008
   
2007
   
2008
   
2007
 
   
(In thousands)
 
Net loss
  $ (464 )   $ (1,070 )   $ (1,134 )   $ (1,634 )
Other comprehensive income (loss):
                               
Change in net unrealized gain on investment, net of taxes of $0
    -       2       7       10  
Reclassification adjustment for net realized gain on sale of investment
    -       -       (97 )     -  
Change in translation adjustments, net of taxes of $0
    87       21       187       60  
Total comprehensive loss
  $ (377 )   $ (1,047 )   $ (1,037 )   $ (1,564 )

9.    Litigation Settlements

Securities Litigation Settlements

Securities Class Action Lawsuits (“Class Action”)
 
Beginning on May 15, 2002, a number of securities class actions were filed against the Company and certain of its current and former directors and former officers alleging violations of the federal securities laws.  These actions were consolidated into a single action pending in the United States District Court for the Central District of California entitled In re Lantronix, Inc. Securities Litigation, Case No. CV 02-3899 GPS (JTLx).  After the Court appointed a lead plaintiff, amended complaints were filed by the plaintiff, and the defendants filed various motions to dismiss directed at particular allegations.  Through that process, certain of the allegations were dismissed by the Court.
 
On October 18, 2004, the plaintiff filed the third amended complaint, which was the operative complaint in the action.  The complaint alleged violations of Sections 11 and 15 of the Securities Act of 1933, as amended (the “Securities Act”) and violations of Sections 10(b) and 20(a) and Rule 10b-5 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”).  The Securities Act claims were brought on behalf of all persons who purchased common stock of Lantronix pursuant or traceable to the Company’s August 4, 2000 initial public offering (“IPO”).  The Exchange Act claims were based on alleged misstatements related to the Company’s financial results that were contained in the Registration Statement and Prospectus for the IPO.  The claims brought under the Exchange Act were brought on behalf of all persons and entities that purchased or acquired Lantronix securities from November 1, 2000 through May 30, 2002 (the “Class Period”).  The complaint alleged that defendants issued false and misleading statements concerning the business and financial condition in order to allegedly inflate the value of the Company’s securities during the Class Period.  The complaint alleged that during the Class Period, Lantronix overstated financial results through improper revenue recognition and failure to comply with GAAP.
 
7

 
The Company reached an agreement with plaintiffs to settle the Class Action lawsuit. The Company also reached agreements with its relevant insurance carriers with respect to the funding of the cash portions of the settlement with plaintiffs, and the cash funding of the settlement has been completed.   Under the terms of the agreement with the Class Action plaintiffs, the Company was not required to contribute any cash to the Class Action settlement, as all cash contributed would be from the Company’s insurance carriers.  However, as part of the agreement with the plaintiffs in the Class Action lawsuit, the Company agreed to issue certain Lantronix securities to the plaintiffs.  As a result of the anticipated issuance of such securities, and in connection with the issuance of securities for the settlement of the Synergetic action described in detail in previous filings, the Company recorded a charge of $1.2 million in the consolidated statement of operations for the fiscal year ended June 30, 2006.  On December 11, 2006, the United States District Court for the Central District of California gave its final approval to the settlement and issued a final order and judgment in the matter.  During the fiscal quarter ended December 31, 2006, the insurance carriers funded their share of the settlement, which totaled $13.9 million.  On January 10, 2007, the settlement of the Company’s securities litigation became final and effective.  During the fiscal quarter ended March 31, 2007, the Company reduced its accrued settlement liability and settlement recovery by $13.9 million in connection with the settlement becoming final and effective.  During March 2008, the Company distributed warrants to purchase 1,079,615 shares of Lantronix common stock to the class action plaintiffs as final consideration for the remaining settlement liability.  Per the terms of the settlement agreement, the number of shares issued pursuant to the warrants was determined by using the Black-Scholes model option-pricing formula using a contract life of four years and a strike price of $3 above the average trading price of the Company’s common stock over the 45 trading days ending two trading days prior to the issuance date (20 days after the settlement date) of the warrants.

10.    Litigation

 From time to time, the Company is subject to other legal proceedings and claims in the ordinary course of business. Except as discussed in Note 9, the Company is currently not aware of any such legal proceedings or claims that it believes will have, individually or in the aggregate, a material adverse effect on its business, prospects, financial position, operating results or cash flows.
 
During 2006, the Company concluded multiple securities lawsuits and litigation with a former executive officer.  The Company may have an obligation to continue to indemnify the former executive officer and defend the securities violation that he has been charged with.  There is a risk that the Company’s insurance carriers may not reimburse the Company for such costs.  Accordingly, legal expenses for this former executive officer’s defense are recorded as incurred and reimbursement of the legal expenses from insurance are recorded upon receipt.  As of March 31, 2008, the Company had $62,000 of reimbursable legal expenses recorded as a liability on its consolidated balance sheets.

Item 2.    Management’s Discussion and Analysis of Financial Condition and Results of Operations

Cautionary Statement

You should read the following discussion and analysis in conjunction with our unaudited condensed consolidated financial statements and the related notes thereto contained elsewhere in this Quarterly Report on Form 10-Q.  The information contained in this Quarterly Report is not a complete description of our business.  We urge you to carefully review and consider the various disclosures made by us in this Quarterly Report and in our other reports filed with the Securities and Exchange Commission (“SEC”), including our Annual Report on Form 10-K for the fiscal year ended June 30, 2007 and subsequent reports on our Current Reports on Form 8-K.
 
This Quarterly Report contains forward-looking statements which include, but are not limited to, statements concerning projected net revenues, expenses, gross profit and net income (loss), the need for additional capital, market acceptance of our products, our ability to achieve further product integration, the status of evolving technologies and their growth potential and our production capacity. Among these forward-looking statements are statements regarding a potential decline in net revenue from non-core product lines, potential variances in quarterly operating expenses, the adequacy of existing resources to meet cash needs, some reduction in the average selling prices and gross margins of products, need to incorporate software from third-party vendors and open source software in our future products and the potential impact of an increase in interest rates or fluctuations in foreign exchange rates on our financial condition or results of operations. These forward-looking statements are based on our current expectations, estimates and projections about our industry, our beliefs and certain assumptions made by us. Words such as “anticipates,” “expects,” “intends,” “plans,” “believes,” “seeks,” “estimates,” “may,” “will” and variations of these words or similar expressions are intended to identify forward-looking statements. In addition, any statements that refer to expectations, projections or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. These statements are not guarantees of future performance and are subject to certain risks, uncertainties and assumptions that are difficult to predict. Therefore, our actual results could differ materially and adversely from those expressed in any forward-looking statements as a result of various factors, including but not limited to those identified under the heading “Risk Factors” set forth in Part II, Item 1A hereto. We undertake no obligation to revise or update publicly any forward-looking statements for any reason.
 
8


Overview

We design, develop and market devices that make it possible to access, manage, control and configure electronic products over the Internet or other networks. We are a leader in providing innovative networking solutions. We were initially formed as “Lantronix,” a California corporation, in June 1989. We reincorporated as “Lantronix, Inc.,” a Delaware corporation, in May 2000.
 
We have a history of providing devices that enable information technology (“IT”) equipment to network using standard protocols for connectivity, including Ethernet and wireless. Our first device was a terminal server that allowed “dumb” terminals to connect to a network. Building on the success of our terminal servers, in 1991 we introduced a complete line of print servers that enabled users to inexpensively share printers over a network. Since then, we have continually refined our core technology and have developed additional innovative networking solutions that expand upon the business of providing our customers network connectivity. With the expansion of networking and the Internet, our technology focus has been increasingly expanded beyond IT equipment, so that our device solutions provide a product manufacturer with the ability to network its products within the industrial, service and commercial markets referred to as machine-to-machine (“M2M”) networking.
 
The following describes our device networking product lines:

·      
Device Enablement – We offer an array of embedded and external device enablement solutions that enable integrators and manufacturers of electronic and electro-mechanical products to add network connectivity, manageability and control.  Our customers’ products originate from a wide variety of applications within the M2M market, from blood analyzers that relay critical patient information directly to a hospital’s information system, to simple devices such as time clocks, allowing the user to obtain information from these devices and to improve how they are managed and controlled.  We also offer products such as multi-port device servers that enable devices outside the data center to cost effectively share the network connection and convert various protocols to industry standard interfaces such as Ethernet and the Internet.

·     
Device Management –We offer off-the-shelf appliances such as console servers, digital remote keyboard, video, mouse extenders, and power control products that enable IT professionals to remotely connect, monitor and control network infrastructure equipment, distributed branch office equipment and large groups of servers using highly secure out-of-band management technology.  In addition, we offer off-the-shelf appliances that enable IT professionals to reliably, remotely and simply monitor, configure and manage multiple devices from a single point of control.

The following describes our non-core product line:

·      
Non-core – Over the years, we have innovated or acquired various product lines that are no longer part of our primary, core markets described above. In general, these non-core businesses represent decreasing markets and we minimize research and development in these product lines. Included in this category are terminal servers, visualization solutions, legacy print servers, software and other miscellaneous products. We have announced the end-of-life for almost all of our non-core products and expect a steep decline in non-core revenues in fiscal 2008 while we complete the exit of this product category.

 Financial Highlights and Other Information for the Three Months Ended March 31, 2008

The following is a summary of the key factors and significant events that impacted our financial performance during the three months ended March 31, 2008:

·      
Net revenues were $14.5 million for the three months ended March 31, 2008, an increase of $1.3 million or 9.7% as compared to $13.3 million for the three months ended March 31, 2007.  The increase was primarily the result of a $2.1 million or 17.8% increase in our device networking product lines offset by a $776,000, or 46.6% decrease in our non-core product lines.
 
·      
Gross profit as a percentage of net revenues was 50.4% for the three months ended March 31, 2008 as compared to 51.8% reported for the three months ended March 31, 2007.  The decrease in gross profit margin percent was primarily attributable to the product mix as a result of an increase in embedded device networking product sales as a percent of net revenues.

9


·      
Loss from operations was $373,000, or 2.6%, of net revenues for the three months ended March 31, 2008 as compared to a loss from operations of $1.1 million, or 7.9%, of net revenues for the three months ended March 31, 2007.

·      
Net loss of $464,000, or $0.01 per basic and diluted share, for the three months ended March 31, 2008, decreased from a net loss of $1.1 million, or $0.02 per basic and diluted share, for the three months ended March 31, 2007.

·      
Cash, cash equivalents and marketable securities were $7.3 million as of March 31, 2008 as compared to $7.7 million as of June 30, 2007.

·      
Net accounts receivable were $2.8 million as of March 31, 2008 as compared to $3.4 million as of June 30, 2007. Annualized days sales outstanding (“DSO”) in receivables were 19 days for the three months ended March 31, 2008 as compared to 21 days for the three months ended June 30, 2007. Our accounts receivable and DSO are primarily affected by the timing of shipments within a quarter, our collections performance and the fact that a significant portion of our revenues are recognized on a sell-through basis (upon shipment from distributor inventories rather than as goods are shipped to distributors).

·      
Net inventories were $8.1 million as of March 31, 2008 as compared to $11.0 million as of June 30, 2007. Annualized inventory turns were 3.0 for the three months ended March 31, 2008 as compared to 2.8 for the three months ended June 30, 2007.

Critical Accounting Policies and Estimates

The accounting policies that have the greatest impact on our financial condition and results of operations and that require the most judgment are those relating to revenue recognition, warranty reserves, allowance for doubtful accounts, inventory valuation, valuation of deferred income taxes, goodwill and purchased intangible assets and legal settlement costs. These policies are described in further detail in our Annual Report on Form 10-K for the fiscal year ended June 30, 2007.  There have been no significant changes in our critical accounting policies and estimates during the nine months ended March 31, 2008 as compared to what was previously disclosed in our Annual Report on Form 10-K for the fiscal year ended June 30, 2007.

Recent Accounting Pronouncements
 
Recent accounting pronouncements issued by the Financial Accounting Standards Board (including its Emerging Issues Task Force), the American Institute of Certified Public Accountants, and the SEC did not or are not believed by management to have a material impact on the Company’s present or future consolidated financial statements.
 
10


Consolidated Results of Operations

The following table presents the percentage of net revenues represented by each item in our condensed consolidated statement of operations:
 
   
Three Months Ended
 
Nine Months Ended
   
March 31,
 
March 31,
   
2008
 
2007
 
2008
 
2007
                 
Net revenues
 
100.0%
 
100.0%
 
100.0%
 
100.0%
Cost of revenues
 
49.6%
 
48.2%
 
49.5%
 
48.6%
Gross profit
 
50.4%
 
51.8%
 
50.5%
 
51.4%
Operating expenses:
               
Selling, general and administrative
 
41.1%
 
45.3%
 
41.0%
 
43.2%
Research and development
 
11.7%
 
14.3%
 
12.2%
 
13.5%
Litigation settlement costs
 
0.0%
 
0.0%
 
0.0%
 
0.2%
Amortization of purchased intangible assets
 
0.1%
 
0.1%
 
0.1%
 
0.1%
Total operating expenses
 
53.0%
 
59.7%
 
53.4%
 
57.1%
Loss from operations
 
(2.6%)
 
(7.9%)
 
(2.9%)
 
(5.7%)
Interest expense, net
 
(0.3%)
 
(0.1%)
 
(0.3%)
 
(0.0%)
Other (expense) income, net
 
(0.1%)
 
0.0%
 
0.3%
 
1.8%
Loss before income taxes
 
(2.9%)
 
(8.0%)
 
(2.9%)
 
(3.9%)
Provision (benefit) for income taxes
 
0.2%
 
0.1%
 
(0.3%)
 
0.1%
Net loss
 
(3.2%)
 
(8.1%)
 
(2.6%)
 
(4.0%)
 
Comparison of the Three and Nine Months Ended March 31, 2008 and 2007

Net Revenues by Product Line

The following table presents net revenues by product line:
 
   
Three Months Ended March 31,
             
         
% of Net
         
% of Net
   
Change
 
   
2008
   
Revenues
   
2007
   
Revenues
   
$
   
%
 
   
(In thousands, except percentages)
 
Device enablement
  $ 11,878       81.7%     $ 9,864       74.4%     $ 2,014       20.4%  
Device management
    1,775       12.2%       1,725       13.0%       50       2.9%  
Device networking
    13,653       93.9%       11,589       87.4%       2,064       17.8%  
Non-core
    888       6.1%       1,664       12.6%       (776 )     (46.6%)  
Net revenues
  $ 14,541       100.0%     $ 13,253       100.0%     $ 1,288       9.7%  
 
The increase in net revenues for the three months ended March 31, 2008 as compared to the three months ended March 31, 2007 was primarily due to the increase in net revenues from our device enablement product lines, offset by a decrease in our non-core product lines.  The increase in our device enablement product lines was primarily due to an increase in our embedded device enablement products, specifically our XPort product family.  We are no longer investing in the development of our non-core product lines and expect net revenues related to these products to continue to decline in the future as we focus our investment on our device networking product lines.
 
11

 
The following table presents net revenues by product line:

   
Nine Months Ended March 31,
       
         
% of Net
         
% of Net
   
Change
 
   
2008
   
Revenue
   
2007
   
Revenue
   
$
   
%
 
   
(In thousands, except percentages)
 
Device enablement
  $ 32,992       77.0%     $ 29,700       73.2%     $ 3,292       11.1%  
Device management
    6,601       15.4%       5,999       14.8%       602       10.0%  
Device networking
    39,593       92.4%       35,699       88.0%       3,894       10.9%  
Non-core
    3,279       7.6%       4,897       12.0%       (1,618 )     (33.0%)  
Net revenues
  $ 42,872       100.0%     $ 40,596       100.0%     $ 2,276       5.6%  
 
The increase in net revenues for the nine months ended March 31, 2008 as compared to the nine months ended March 31, 2007 was the result of an increase in net revenues from our device enablement and device management product lines, offset by a decrease in our non-core product lines.  The increase in our device enablement product lines was due to increases in our embedded and external device enablement product lines.  The increase in device management was due to an increase in our SecureLinx products.  We are no longer investing in the development of our non-core product lines and expect net revenues related to these products to continue to decline in the future as we focus our investment on our device networking product lines.

Net Revenues by Region

The following table presents net revenues by geographic region:
 
   
Three Months Ended March 31,
       
         
% of Net
         
% of Net
   
Change
 
   
2008
   
Revenues
   
2007
   
Revenues
   
$
   
%
 
   
(In thousands, except percentages)
 
Americas
  $ 8,294       57.0%     $ 8,247       62.2%     $ 47       0.6%  
EMEA
    4,204       28.9%       3,484       26.3%       720       20.7%  
Asia Pacific
    2,043       14.1%       1,522       11.5%       521       34.2%  
Net revenues
  $ 14,541       100.0%     $ 13,253       100.0%     $ 1,288       9.7%  
 
The increase in net revenues for the three months ended March 31, 2008 as compared to the three months ended March 31, 2007 was primarily a result of an increase in net revenues in the EMEA (“Europe, Middle East and Africa”) and Asia Pacific regions.  The increase in net revenues in the EMEA and Asia Pacific regions was primarily attributable to an increase in our device enablement product lines.
 
The following table presents net revenues by geographic region:

   
Nine Months Ended March 31,
           
         
% of Net
         
% of Net
   
Change
 
   
2008
   
Revenue
   
2007
   
Revenue
   
$
   
%
 
   
(In thousands, except percentages)
 
Americas
  $ 25,137       58.6%     $ 25,476       62.8%     $ (339 )     (1.3%)  
EMEA
    11,714       27.3%       10,195       25.1%       1,519       14.9%  
Asia Pacific
    6,021       14.1%       4,925       12.1%       1,096       22.3%  
Net revenues
  $ 42,872       100.0%     $ 40,596       100.0%     $ 2,276       5.6%  
 
The increase in net revenues for the nine months ended March 31, 2008 as compared to the nine months ended March 31, 2007 was primarily a result of an increase in net revenues in the EMEA and Asia Pacific regions offset by a decrease in the Americas region.  The increase in net revenues in the EMEA region was primarily attributable to an increase in sales of our device enablement product lines.  The increase in net revenues in Asia Pacific region was primarily attributable to an increase in our device enablement and device management product lines offset by a decrease in our non-core product line.  The decrease in the Americas region was primarily due to the expected decrease in our non-core product lines offset by an increase in device enablement and device management product lines.
 
12


Gross Profit

Gross profit represents net revenues less cost of revenues. Cost of revenues consisted primarily of the cost of raw material components, subcontract labor assembly from contract manufacturers, manufacturing overhead, amortization of purchased intangible assets, establishing or relieving inventory reserves for excess and obsolete products or raw materials, warranty costs, royalties and share-based compensation.
 
The following table presents gross profit:
   
Three Months Ended March 31,
           
         
% of Net
         
% of Net
   
Change
 
   
2008
   
Revenues
   
2007
   
Revenues
   
$
   
%
 
   
(In thousands, except percentages)
 
Gross profit
  $ 7,334       50.4%     $ 6,866       51.8%     $ 468       6.8%  
 
The decrease in gross profit margin percent was primarily attributable to the product mix as a result of an increase in embedded device networking products as a percent of net revenues.
 
The following table presents gross profit:
 
   
Nine Months Ended March 31,
           
         
% of Net
         
% of Net
   
Change
 
   
2008
   
Revenue
   
2007
   
Revenue
   
$
   
%
 
   
(In thousands, except percentages)
 
Gross profit
  $ 21,638       50.5%     $ 20,873       51.4%     $ 765       3.7%  
 
The decrease in gross profit margin percent was primarily attributable to an increase in certain inventory reserves in connection with a review of our product offerings as part of our effort to simplify our product portfolio by discontinuing slow-moving and non-strategic products.

Selling, General and Administrative

Selling, general and administrative expenses consisted of personnel-related expenses including salaries and commissions, share-based compensation, facility expenses, information technology, trade show expenses, advertising, and legal and accounting fees offset by reimbursement of legal fees from insurance proceeds.
 
The following table presents selling, general and administrative expenses:
 
   
Three Months Ended March 31,
           
       
% of Net
     
% of Net
 
Change
 
   
2008
 
Revenues
 
2007
 
Revenues
 
$
   
%
 
   
(In thousands, except percentages)
 
Personnel-related expenses
  $ 3,523       $ 3,324       $ 198       6.0%  
Professional fees & outside services
    516         676         (160 )     (23.7%)  
Advertising and marketing
    825         718         107       14.9%  
Facilities
    390         523         (133 )     (25.4%)  
Share-based compensation
    186         292         (105 )     (36.1%)  
Depreciation
    95         68         27       39.7%  
Other
    447         400         47       11.8%  
Selling, general and administrative
  $ 5,982  
41.1%
  $ 6,001  
45.3%
  $ (19 )     (0.3%)  
 
In order of significance, the decrease in selling, general and administrative expenses for the three months ended March 31, 2008 as compared to the three months ended March 31, 2007 was primarily due to: (i) a decrease in professional fees & outside services, (ii) a decrease in facilities as a result of lower insurance and other allocated facility costs, and (iii) a decrease in share-based compensation; offset by (iv) an increase in personnel-related expenses and (v) an increase in advertising and marketing spending due to the timing of product launches.
 
13

 
The following table presents selling, general and administrative expenses:
   
Nine Months Ended March 31,
           
       
 % of Net
     
 % of Net
 
Change
 
   
2008
 
 Revenues
 
2007
 
 Revenues
 
$
   
%
 
   
(In thousands, except percentages)
 
Personnel-related expenses
  $ 10,108       $ 9,375       $ 733       7.8%  
Professional fees & outside services
    1,992         2,281         (289 )     (12.7%)  
Advertising and marketing
    2,146         2,305         (159 )     (6.9%)  
Facilities
    1,162         1,540         (378 )     (24.5%)  
Share-based compensation
    588         702         (114 )     (16.2%)  
Depreciation
    271         211         60       28.4%  
Other
    1,325         1,142         183       16.0%  
Selling, general and administrative
  $ 17,592  
41.0%
  $ 17,556  
43.2%
  $ 36       0.2%  
 
In order of significance, the change in selling, general and administrative expenses for the nine months ended March 31, 2008 as compared to the nine months ended March 31, 2007 was primarily due to: (i) an increase in personnel-related expenses as a result of severance charges related to the departure of the former president and chief executive officer and other former employees; offset by (ii) a decrease in facilities as a result of lower insurance and other allocated facility costs, (iii) a decrease in professional fees & outside services and (iv) a decrease in advertising and marketing spending due to the timing of product launches and more focused marketing spending.

Research and Development

Research and development expenses consisted of personnel-related expenses including share-based compensation, as well as expenditures to third-party vendors for research and development activities.
 
The following table presents research and development expenses:

   
Three Months Ended March 31,
         
       
% of Net
     
% of Net
 
Change
 
   
2008
 
Revenues
 
2007
 
Revenues
 
$
   
%
 
   
(In thousands, except percentages)
 
Personnel-related expenses
  $ 1,264       $ 1,354       $ (90)       (6.6%)  
Facilities
    223         176         47       26.7%  
Professional fees & outside services
    53         178         (125)       (70.2%)  
Share-based compensation
    74         97         (23)       (23.7%)  
Depreciation
    14         10         4       40.0%  
Other
    79         83         (4)       (4.8%)  
Research and development
  $ 1,707  
11.7%
  $ 1,898  
14.3%
  $ (191)       (10.1%)  
 
In order of significance, the decrease in research and development expenses for the three months ended March 31, 2008 as compared to the three months ended March 31, 2007 was primarily due to: (i) a decrease in professional fees & outside services and (ii) a decrease in personnel-related expenses.
 
14

 
The following table presents research and development expenses:
   
Nine Months Ended March 31,
         
       
% of Net
     
% of Net
 
Change
 
   
2008
 
Revenues
 
2007
 
Revenues
 
$
   
%
 
   
(In thousands, except percentages)
 
Personnel-related expenses
  $ 3,852       $ 3,967       $ (115)       (2.9%)  
Facilities
    651         490         161       32.9%  
Professional fees & outside services
    187         396         (209)       (52.8%)  
Share-based compensation
    260         285         (25)       (8.8%)  
Depreciation
    40         30         10       33.3%  
Other
    243         330         (87)       (26.4%)  
Research and development
  $ 5,233  
12.2%
  $ 5,498  
13.5%
  $ (265)       (4.8%)  
 
In order of significance, the decrease in research and development expenses for the nine months ended March 31, 2008 as compared to the nine months ended March 31, 2007 was primarily due to: (i) a decrease in professional fees & outside services and (ii) a decrease in personnel-related expenses.

Provision for Income Taxes
 
On July 1, 2007, we adopted Financial Accounting Standards Board Interpretation No. 48, “Accounting for Uncertainty in Income Taxes, an Interpretation of FASB Statement No. 109” (“FIN 48”).  In connection with the adoption of FIN 48, we recognized an adjustment of approximately $226,000 to the beginning balance of accumulated deficit on our consolidated balance sheet.  Our continuing practice is to recognize interest and/or penalties related to income tax matters in income tax expense. As of March 31, 2008, we had recorded $151,000 of uncertain tax positions including approximately $74,000 of accrued interest and penalties related to uncertain tax positions.
 
At July 1, 2007, our fiscal 2001 through fiscal 2007 tax years remain open to examination by the Federal and state taxing authorities.  However, we have net operating losses (“NOLs”) beginning in fiscal 2001 which would cause the statute of limitations to remain open for the year in which the NOL was incurred.
 
The following table presents our effective tax rate based upon our income tax provision:
 
   
Three Months Ended
March 31,
   
Nine Months Ended
March 31,
 
   
2008
   
2007
   
2008
   
2007
 
Effective tax rate
    8%       1%       9%       2%  
 
We utilize the liability method of accounting for income taxes as set forth in Statement of Financial Accounting Standards No. 109, “Accounting for Income Taxes.”  The tax benefit during the fiscal quarter ended March 31, 2008 is the result of a reduction in estimated foreign taxes and penalties.   The federal statutory rate was 34% for all periods.  The difference between our effective tax rate and the federal statutory rate resulted primarily from the effect of our domestic losses recorded without a tax benefit, as well as the effect of foreign earnings taxed at rates differing from the federal statutory rate. We record net deferred tax assets to the extent we believe these assets will more likely than not be realized. As a result of our cumulative losses, we provided a full valuation allowance against our domestic net deferred tax assets for the fiscal quarters ended March 31, 2008 and 2007.

Other (Expense) Income, Net

Other (expense) income, net consists of gains (losses) on the sale of investments, foreign currency transactions and the disposal of fixed assets.
 
15

 
The following tables present other (expense) income, net:
 
   
Three Months Ended March 31,
           
         
% of Net
         
% of Net
   
Change
 
   
2008
   
Revenue
   
2007
   
Revenue
   
$
   
%
 
   
(In thousands, except percentages)
 
Other (expenses) income, net
  $ (16)       -0.1%     $ 6        0.0%     $ (22)       (366.7%)  
 
   
Nine Months Ended March 31,
           
         
% of Net
         
% of Net
   
Change
 
   
2008
   
Revenue
   
2007
   
Revenue
   
$
   
%
 
   
(In thousands, except percentages)
 
Other (expenses) income, net
  $ 115        0.3%     $    733        1.8%     $ (618)       (84.3%)  
 
The decrease in other (expense) income, net for the nine months ended March 31, 2008 as compared to the nine months ended March 31, 2007 is primarily due to $700,000 of income recognized on the sale of our investment in Xanboo during December of 2006. The decrease was partially offset by the sale of our marketable securities of approximately $104,000 in the nine months ended March 31, 2008.

Liquidity and Capital Resources

Since inception to date, we have financed our operations primarily through the issuance of common stock and operating activities. We refer to the sum of cash and cash equivalents and marketable securities as “cash” for the purposes of discussing our cash balance and liquidity.

The following table presents details of our working capital and cash:
   
March 31,
   
June 30,
   
Increase
 
   
2008
   
2007
   
(Decrease)
 
   
(In thousands)
 
Working capital
  $ 6,895     $ 5,587     $ 1,308  
Cash and cash equivalents
  $ 7,297     $ 7,582     $ (285 )
Marketable securities
    -       97       (97 )
Total cash, cash equivalents and marketable securities
  $ 7,297     $ 7,679     $ (382 )
 
Our cash balance decreased compared to prior year end as a result of our cash management activities, which included the timing of cash payments to our vendors and the timing of cash receipts from our customers.  The increase in working capital as of March 31, 2008 is primarily due to a $1.1 million reduction in the accrued settlement liability as a result of the distribution of warrants to purchase Lantronix common stock as final consideration for the settlement of the shareholder lawsuit.

Our future capital requirements depend on many factors, including the timing and amount of our net revenues, research and development, expenses associated with any strategic partnerships or acquisitions and infrastructure investments, and expenses related to government investigations and litigation, which could affect our ability to generate additional cash. If cash generated from operations and financing activities is insufficient to satisfy our working capital requirements, we may need to raise capital by borrowing funds through bank loans, the selling of securities or other means. There can be no assurance that we will be able to raise any such capital on terms acceptable to us, if at all. If we are unable to secure additional financing, we may not be able to develop or enhance our products, take advantage of future opportunities, respond to competition or continue to operate our business.
 
In May 2006, we entered into a two-year secured revolving Loan and Security Agreement ("Line of Credit”) with a bank, which provides for borrowings up to $5.0 million. The borrowing capacity is limited to eligible accounts receivable as defined under the Line of Credit. Borrowings under the Line of Credit bear interest at the prime rate plus 1.75% per annum. We are required to pay an unused line fee of 0.50% on the unused portion of the Line of Credit. As of March 31, 2008 and June 30, 2007, we had no borrowings against the Line of Credit.  Our Line of Credit expires in May 2008.  We are currently negotiating terms for a new debt agreement.
 
16

 
The following table presents our available borrowing capacity and outstanding letters of credit, which were used to secure equipment leases, deposits for a building lease and security deposits:
 
 
   
March 31,
   
June 30,
 
   
2008
   
2007
 
   
(In thousands)
 
Available borrowing capacity
  $ 1,717     $ 3,462  
Outstanding letters of credit
  $ 2,269     $ 1,280  
 
As of March 31, 2008 and June 30, 2007, approximately $814,000 and $2.0 million, respectively, of our cash was held in foreign subsidiary bank accounts.  Such cash is unrestricted with regard to foreign liquidity needs; however, our ability to utilize a portion of this cash to satisfy liquidity needs outside of such foreign locations is subject to approval by the foreign location board of directors.

Cash Flows

The following table presents the major components of the consolidated statements of cash flows:
 
   
Three Months Ended
   
Nine Months Ended
 
   
March 31,
   
March 31,
 
   
2008
   
2007
   
2008
   
2007
 
         
(In thousands)
       
Net cash provided by (used in):
                       
Net loss
  $ (464 )   $ (1,070 )   $ (1,134 )   $ (1,634 )
Non-cash operating expenses, net
    487       461       1,687       672  
Changes in operating assets and liabilities:
    -                          
Accounts receivable
    446       710       594       309  
Inventories
    1,836       (1,235 )     2,540       (1,580 )
Contract manufacturers' receivable
    (320 )     (321 )     (51 )     (305 )
Prepaid expenses and other current assets
    (274 )     73       (139 )     48  
Other assets
    28       3       11       (3 )
Accounts payable
    (1,271 )     1,131       (3,543 )     2,403  
Accrued payroll and related expenses
    (437 )     (133 )     (104 )     171  
Accrued settlements
    -       -       -       (400 )
Warranty reserve
    -       (29 )     (104 )     (248 )
Other liabilities
    54       (27 )     (141 )     (644 )
Net cash provided (used) in operating activities
    85       (437 )     (384 )     (1,211 )
Net cash (used) provided in investing activities
    (131 )     (125 )     (279 )     304  
Net cash provided by financing activities
    27       280       178       597  
Effect of foreign exchange rate changes on cash
    92       21       200       64  
Increase (decrease) in cash and cash equivalents
  $ 73     $ (261 )   $ (285 )   $ (246 )
 
Operating activities provided cash during the three months ended March 31, 2008. This was the result of non-cash operating expenses and cash provided by operating assets and liabilities, offset by a net loss. The non-cash items that had a significant impact on the net loss included share-based compensation, depreciation and provisions for inventories.  In order of significance, the changes in operating assets and liabilities that had a significant impact on the cash provided by operating activities included (i) a decrease in inventory, and (ii) a decrease in accounts receivable due to the timing of collections and linearity of sales; offset by (iii) a decrease in accounts payable due to the timing of payments.

Operating activities used cash during the three months ended March 31, 2007. This was the result of a net loss, offset by cash provided by operating assets and liabilities and non-cash operating expenses.  The non-cash items that had a significant impact on net loss included share-based compensation and depreciation. In order of significance, the changes in operating assets and liabilities that had a significant impact on the cash provided by operating activities included (i) an increase in accounts payable as a result of the timing of payments to vendors and (ii) a decrease in accounts receivable due to the timing of collections and linearity of sales; offset by (iii) an increase in inventories due to the timing of shipments.

Investing activities used cash during the three months ended March 31, 2008 and 2007 due to the purchase of property and equipment.

Financing activities provided cash during the three months ended March 31, 2008 and 2007 due to proceeds from the sale of common shares through employee stock option exercises, which was offset by repayments on capital lease obligations.

17

 
Operating activities used cash during the nine months ended March 31, 2008. This was the result of a net loss, and cash used by operating assets and liabilities, which was offset by non-cash operating expenses. The non-cash items that had a significant impact on the net loss included share-based compensation, depreciation, provisions for inventories and a gain on the sale of marketable securities. In order of significance, the changes in operating assets and liabilities which had a significant impact on the cash used in operating activities included (i) a decrease in accounts payable due to the timing of payments; offset by (ii) a decrease in inventory due to the timing of shipments and (iii) an decrease in accounts receivable due to the timing of shipment and collections.

Operating activities used cash during the nine months ended March 31, 2007. This was the result of a net loss, and cash used by operating assets and liabilities, which was offset by non-cash operating expenses. The non-cash items that had a significant impact on the net loss included a gain on the sale of the company’s investment in Xanboo, share-based compensation and depreciation. In order of significance, the changes in operating assets and liabilities which had a significant impact on the cash used in operating activities included (i) an increase in inventories, (ii) a decrease in other liabilities as a result of a decrease in customer deposits and the timing of payments to vendors, (iii) a decrease in accrued settlements as a result of the payment of the Digi settlement and (iv) a reduction in the warranty reserve to reflect lower expected warranty return rates; offset by (v) an increase in accounts payable as a result of the timing of cash payments to vendors.

Investing activities used cash during the nine months ended March 31, 2008.  This was due to the purchase of property and equipment, which was offset by proceeds from the sale of marketable securities.

Investing activities provided cash during the nine months ended March 31, 2007. This was due to the sale of the Company’s investment in Xanboo for $700,000, which was offset by the purchase of property and equipment.

Financing activities provided cash during the nine months ended March 31, 2008 and 2007. This was due to proceeds from the sale of common shares through employee stock option exercises, which was offset by repayments on capital lease obligations.

Off-Balance Sheet Arrangements

We did not have any off balance sheet arrangements as of March 31, 2008.

Item 3.   Quantitative and Qualitative Disclosures About Market Risk

We do not use derivative financial instruments for speculative or trading purposes. We place our investments in instruments that meet high credit quality standards, as specified in our investment policy.

Interest Rate Risk
 
Our exposure to interest rate risk is limited to the exposure related to our cash, cash equivalents and marketable securities. Our cash and cash equivalents are held in cash deposit accounts and, as such, we believe our cash and cash equivalents are not subject to significant interest rate risk. We believe our marketable securities would not decline in value by a significant amount if interest rates increase, and therefore would not have a material effect on our financial condition or results of operations.

The following table presents our cash, cash equivalents and marketable securities:
 
   
March 31,
   
June 30,
 
   
2008
   
2007
 
   
(In thousands)
Cash and cash equivalents
  $ 7,297     $ 7,582  
Marketable securities
    -       97  
Total cash, cash equivalents and marketable securities
  $ 7,297     $ 7,679  
 
Foreign Currency Risk
 
We hold a significant portion of our cash balance in foreign currencies (particularly the Euro) and, as such, we are subject to foreign currency fluctuations. In addition, we sell products internationally. As a result, our financial results could be harmed by factors such as changes in foreign currency exchange rates or weak economic conditions in foreign markets. We do not currently enter into forward exchange contracts to hedge exposure denominated in foreign currencies or any other derivative financial instruments for trading or speculative purposes. In the future, if we feel our foreign currency exposure has increased, we may consider entering into hedging transactions to help mitigate that risk.

18

 
The following table presents our cash balance held in foreign currencies:
 
   
March 31,
   
June 30,
 
   
2008
   
2007
 
   
(In thousands)
 
Cash held in foreign currencies
  $ 1,827     $ 2,042  
 
Item 4.    Controls and Procedures

(a) Evaluation of disclosure controls and procedures
 
We carried out an evaluation, under the supervision and with the participation of our management, including our President and Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) as of the end of our fiscal quarter ended March 31, 2008. Based upon that evaluation, our President and Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures are effective in ensuring that information required to be disclosed by us in reports that we file or submit under the Exchange Act (i) is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and (ii) is accumulated and communicated to our management, including our President and Chief Executive Officer and Chief Financial Officer to allow timely decisions regarding required disclosure.
 
(b) Changes in internal controls over financial reporting
 
There have been no changes in our internal controls over financial reporting identified during the fiscal quarter that ended March 31, 2008 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
 
PART II. OTHER INFORMATION

Item 1.   Legal Proceedings

The information set forth in Notes 9 and 10 to our notes to the unaudited condensed consolidated financial statements of Part I, Item 1 of this Quarterly Report is hereby incorporated by reference.

Item 1A. Risk Factors
 
We operate in a rapidly changing environment that involves numerous risks and uncertainties.  Before deciding to purchase, hold or sell our common stock, you should carefully consider the risks described in this section. This section should be read in conjunction with the unaudited consolidated financial statements and accompanying notes thereto, and Management’s Discussion and Analysis of Financial Condition and Results of Operations included in this Report. If any of these risks or uncertainties actually occurs with material adverse effects on us, our business, financial condition and results of operations could be seriously harmed. In that event, the market price for our common stock could decline and you may lose all or part of your investment.
 
Our quarterly operating results may fluctuate, which could cause our stock price to decline.
 
We have experienced, and expect to continue to experience, significant fluctuations in net revenues, expenses and operating results from quarter to quarter. We, therefore, believe that quarter-to-quarter comparisons of our operating results are not a good indication of our future performance, and you should not rely on them to predict our future performance or the future performance of our stock. A high percentage of our operating expenses are relatively fixed and are based on our expectations of future net revenues. If we were to experience a reduction in revenues in a quarter, we would likely be unable to adjust our short-term expenditures. If this were to occur, our operating results for that fiscal quarter would be harmed. If our operating results in future fiscal quarters fall below the expectations of market analysts and investors, the price of our common stock would likely fall. Other factors that might cause our operating results to fluctuate on a quarterly basis include:
 
19


·       
changes in the mix of net revenues attributable to higher-margin and lower-margin products;

·       
customers’ decisions to defer or accelerate orders;

·       
variations in the size or timing of orders for our products;

·       
changes in demand for our products;

·       
fluctuations in exchange rates;

·       
defects and other product quality problems;

·       
loss or gain of significant customers;

·       
short-term fluctuations in the cost or availability of our critical components;

·       
announcements or introductions of new products by our competitors;

·       
effects of terrorist attacks in the U.S. and abroad; and

·       
changes in demand for devices that incorporate our products.

Our common stock may be delisted, which could significantly harm our business.

Our common stock is currently listed on The Nasdaq Capital Market under the symbol “LTRX.” We currently are not in compliance with the $1.00 minimum bid price requirement for inclusion in The Nasdaq Capital Market; however, we have until June 23, 2008, to regain compliance. At that time we may then be eligible for an additional 180 calendar day grace period in which to regain compliance with the $1.00 minimum bid price requirement. If our common stock was delisted from The Nasdaq Capital Market, some or all of the following could be reduced, harming our investors:

·       
the liquidity of our common stock;

·       
the market price of our common stock;

·       
the number of institutional investors that will consider investing in our common stock;

·       
the number of investors in general that will consider investing in our common stock;

·       
the number of market makers in our common stock;

·       
the availability of information concerning the trading prices;

·       
the number of broker-dealers willing to execute trades in shares of our common stock; and

·       
our ability to obtain financing for the continuation of our operations.

If a major distributor or customer cancels, reduces or delays purchases, our net revenues might decline and our business could be adversely affected.

The number and timing of sales to our distributors have been difficult for us to predict. While our distributors are customers in the sense they buy our products, they are also part of our product distribution system. Some of our distributors could be acquired by a competitor and stop buying product from us.

The following table presents sales to our significant customers as a percentage of net revenues:

20

 
   
Nine Months Ended
 
   
March 31,
 
   
2008
   
2007
 
Top five customers (1)
    38.0%       34.0%  
Tech Data
    13.3%       7.0%  
Ingram Micro
    8.4%       12.0%  
                 
(1) Includes Ingram Micro and Tech Data.
               
 
The loss or deferral of one or more significant customers in a quarter could harm our operating results. We have in the past, and might in the future, lose one or more major customers. If we fail to continue to sell to our major customers in the quantities we anticipate, or if any of these customers terminate our relationship, our reputation, the perception of our products and technology in the marketplace, could be harmed. The demand for our products from our OEM, VAR and systems integrator customers depends primarily on their ability to successfully sell their products that incorporate our device networking solutions technology. Our sales are usually completed on a purchase order basis and we have few long-term purchase commitments from our customers.
 
Our future success also depends on our ability to attract new customers, which often involves an extended selling process. The sale of our products often involves a significant technical evaluation, and we often face delays because of our customers’ internal procedures for evaluating and deploying new technologies. For these and other reasons, the sales cycle associated with our products is typically lengthy, often lasting six to nine months and sometimes longer. Therefore, if we were to lose a major customer, we might not be able to replace the customer in a timely manner, or at all. This would cause our net revenues to decrease and could cause our stock price to decline.
 
If we fail to develop or enhance our products to respond to changing market conditions and government and industry standards, our competitive position will suffer and our business will be adversely affected.
 
Our future success depends in large part on our ability to continue to enhance existing products, lower product cost and develop new products that maintain technological competitiveness and meet government and industry standards. The demand for network-enabled products is relatively new and can change as a result of innovations, new technologies or new government and industry standards. For example, a recent directive in the European Union bans the use of lead and other heavy metals in electrical and electronic equipment after July 1, 2006. As a result, in advance of this deadline, some of our customers selling products in Europe had begun demanding product from component manufacturers that did not contain these banned substances. Any failure by us to develop and introduce new products or enhancements in response to new government and industry standards could harm our business, financial condition or results of operations. These requirements might or might not be compatible with our current or future product offerings. We might not be